All News #Library
Others
Orna Therapeutics Names Joseph Bolen, Ph.D., CEO
31 Mar 2025 //
PR NEWSWIRE
Orna Therapeutics Appoints Frank Neumann, M.D., Ph.D., as Chief Medical Officer
12 Apr 2024 //
PR NEWSWIRE
Orna trims staff in ‘defensive reduction’ despite large financing hauls
30 Nov 2023 //
ENDPTS
Merck bets big on circular RNA, paying $150M to work with Orna
17 Aug 2022 //
FIERCEBIOTECH

Market Place
Sourcing Support